Effect of Acellular Pertussis Vaccine Against Various Strains of Bordetella Pertussis in a Murine Model of Respiratory Infection.

This publication has 12 references indexed in Scilit:

• Differing Protective Effects of Acellular Pertussis Vaccines in Neonatal and Young Mice in a Murine Model of Respiratory Infection.
  Journal of Health Science, 2002
• Polymorphism of Bordetella pertussis Isolates Circulating for the Last 10 Years in France, Where a Single Effective Whole-Cell Vaccine Has Been Used for More than 30 Years
  Journal of Clinical Microbiology, 2001
• Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model
  Vaccine, 2001
• Investigation of an Aerosol Challenge Model as Alternative to the Intracerebral Mouse Protection Test for Potency Assay of Whole Cell Pertussis Vaccines
  Biologicals, 2000
• Efficacy of chemically cross-linked antigens for acellular pertussis vaccine
  Vaccine, 2000
• Efficacy of pertussis vaccines consisted of antigens detoxified with tea-leaf catechins
  Vaccine, 2000
• Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine1Financial support for the present study was provided by the Institut Pasteur Fondation and SmithKline Beecham Biologicals. All animal studies were conducted in accordance with the French and Belgian national legislative guidelines for animal experimentation.1
  Vaccine, 1999
• Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines
  Vaccine, 1999
• Adenylate Cyclase Activity of Bordetella Organisms
  Microbiology and Immunology, 1980
• Mouse Protection Tests in the Study of Pertussis Vaccine
  American Journal of Public Health and the Nations Health, 1947